Financial Performance - For fiscal 2026, Under Armour expects adjusted earnings per share to range from $0.10 to $0.11, an increase from the prior outlook of $0.03 to $0.05 [1] - The company anticipates a loss per share between $1.24 and $1.25 [1] - Adjusted operating income is projected to be approximately $110 million, compared to the previous outlook of $95 million to $110 million [1] - Revenue is expected to decline by approximately 4 percent, an improvement from the prior outlook of a 4 to 5 percent decline [1] Quarterly Results - In the third quarter, Under Armour reported a net loss of $430.8 million, a significant decrease from a net income of $1.2 million in the previous year [2] - The net loss per share for class A, B, and C common stock was $1.01, compared to breakeven in the prior year [2] - Adjusted operating income for the quarter was $26 million, while adjusted net income per share was $0.09, slightly up from $0.08 [2] - Revenue decreased by 5 percent to $1.33 billion, or down 6 percent on a currency-neutral basis [2] Management Commentary - Under Armour's CEO Kevin Plank stated that the third quarter adjusted operating results exceeded expectations and expressed optimism about the progress in reigniting brand momentum despite some non-recurring impacts [3] Market Reaction - In pre-market trading on NYSE, Under Armour shares increased by 3.26 percent to $6.50 [4]

分组1 - IREN Limited reported a quarterly loss of $0.44 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.09, marking an earnings surprise of -371.60% [1] - The company posted revenues of $184.69 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 16.49%, compared to year-ago revenues of $119.59 million [2] - IREN Limited shares have increased by approximately 19% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $268.55 million, while for the current fiscal year, it is $0.67 on revenues of $1.12 billion [7] - The Zacks Industry Rank for Financial - Miscellaneous Services is in the top 33% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

分组1 - Cigna reported quarterly earnings of $8.08 per share, exceeding the Zacks Consensus Estimate of $7.87 per share, and up from $6.64 per share a year ago, representing an earnings surprise of +2.70% [1] - The company achieved revenues of $72.5 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.66%, compared to $65.68 billion in the same quarter last year [2] - Cigna has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed the market with a loss of about 1.3% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $7.24 on revenues of $67.7 billion, and for the current fiscal year, it is $30.37 on revenues of $285.06 billion [7] - The Medical - HMOs industry, to which Cigna belongs, is currently ranked in the bottom 6% of over 250 Zacks industries, which may impact stock performance [8]

分组1 - Evercore reported quarterly earnings of $5.13 per share, exceeding the Zacks Consensus Estimate of $3.83 per share, and showing an increase from $3.41 per share a year ago, resulting in an earnings surprise of +33.81% [1] - The company achieved revenues of $1.3 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 22.27%, compared to revenues of $980.5 million in the same quarter last year [2] - Over the last four quarters, Evercore has consistently surpassed consensus EPS and revenue estimates [2] 分组2 - The stock has underperformed the market with a loss of about 0.5% since the beginning of the year, while the S&P 500 has gained 1.1% [3] - The current consensus EPS estimate for the upcoming quarter is $3.80 on revenues of $969.62 million, and for the current fiscal year, it is $18.09 on revenues of $4.6 billion [7] - The Financial - Investment Bank industry, to which Evercore belongs, is currently ranked in the top 17% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

分组1 - Powell Industries reported quarterly earnings of $3.4 per share, exceeding the Zacks Consensus Estimate of $2.85 per share, and showing an increase from $2.86 per share a year ago, resulting in an earnings surprise of +19.30% [1] - The company posted revenues of $251.18 million for the quarter ended December 2025, which was 2.44% below the Zacks Consensus Estimate, but an increase from $241.43 million year-over-year [2] - Powell Industries has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The stock has gained approximately 38.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is $3.71, with expected revenues of $295.84 million, and for the current fiscal year, the EPS estimate is $15.45 on revenues of $1.18 billion [7] - The Manufacturing - Electronics industry, to which Powell Industries belongs, is currently ranked in the top 40% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - Jack Henry reported quarterly earnings of $1.72 per share, exceeding the Zacks Consensus Estimate of $1.43 per share, and showing an increase from $1.34 per share a year ago, resulting in an earnings surprise of +20.28% [1] - The company achieved revenues of $619.33 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.64% and up from $573.85 million year-over-year [2] - Jack Henry has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed the market with a decline of about 1.8% since the beginning of the year, while the S&P 500 has gained 1.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.47 on revenues of $613.23 million, and for the current fiscal year, it is $6.46 on revenues of $2.5 billion [7] 分组3 - The Computers - IT Services industry, to which Jack Henry belongs, is currently ranked in the top 40% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5] - Jack Henry holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]

分组1 - Kforce reported quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.47 per share, and down from $0.6 per share a year ago, representing an earnings surprise of -8.51% [1] - The company posted revenues of $332.02 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.65%, but down from year-ago revenues of $343.78 million [2] - Kforce shares have increased approximately 14.3% since the beginning of the year, outperforming the S&P 500's gain of 1.4% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.41 on revenues of $319.77 million, and for the current fiscal year, it is $2.28 on revenues of $1.32 billion [7] - The Zacks Industry Rank indicates that the Staffing Firms industry is currently in the bottom 14% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

分组1 - Twist Bioscience reported a quarterly loss of $0.5 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.48, and an improvement from a loss of $0.53 per share a year ago, indicating a surprise of -5.26% [1] - The company generated revenues of $103.7 million for the quarter ended December 2025, slightly missing the Zacks Consensus Estimate by 0.05%, but showing growth from $88.71 million in the same quarter last year [2] - Over the last four quarters, Twist Bioscience has surpassed consensus revenue estimates three times, but only once for EPS estimates [2] 分组2 - The stock has increased by approximately 29.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.4% [3] - The company's earnings outlook is crucial for future stock performance, with current consensus EPS estimates at -$0.46 for the coming quarter and -$1.64 for the current fiscal year [7] - The Medical - Biomedical and Genetics industry, to which Twist Bioscience belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Corporate America’s earnings outlook for 2026 remains solid, according to Goldman strategists, assuaging concerns after an underwhelming reporting season so far https://t.co/peilWIT5So ...

Core Viewpoint - Royal Caribbean's stock has surged due to a strong earnings outlook driven by record cruise bookings and positive demand for future cruises [1] Earnings Results - The company reported a fourth-quarter earnings rise that met Wall Street expectations, contributing to an optimistic full-year profit and revenue outlook [1] - The wave booking season has started strongly, indicating robust demand for cruises [1] Fleet Expansion - Royal Caribbean announced agreements with a shipyard in France to expand its fleet, including additions for river vessels [1]